ReachMD
Be part of the knowledge.™- 0
Ophthalmology
No horizonte do Brasil: Uma perspectiva regional sobre como conseguir supressão de VEGF durável em DMRI e EMD
No horizonte do Brasil: Uma perspectiva regional sobre como conseguir supressão de VEGF durável em DMRI e EMD
- 1
Ophthalmology
Am Horizont in Deutschland: Eine regionale Perspektive auf das Erreichen einer dauerhaften VEGF-Unterdrückung bei nAMD und DMÖ
Am Horizont in Deutschland: Eine regionale Perspektive auf das Erreichen einer dauerhaften VEGF-Unterdrückung bei nAMD und DMÖ
Time Is Vision in nAMD and RVO
Time Is Vision: A Call to Action for Earlier Intervention to Prevent Blindness Due to nAMD and RVO
Time Is Vision: A Call to Action for Earlier Intervention to Prevent Blindness Due to nAMD and RVO
- 1
CME/CE
Take Control of Wet AMD - Patient Education
Take Control of Wet AMD - Patient Education
Clinician's Roundtable
Shedding Light on Spaceflight-Associated Neuro-Ocular Syndrome
Shedding Light on Spaceflight-Associated Neuro-Ocular Syndrome
Everyday Family Medicine
Ocular Manifestations of Rheumatological Conditions
Ocular Manifestations of Rheumatological Conditions
CME/CE
On the Horizon: Strategies for Surgical Success of Durable Anti-VEGF Delivery in nAMD and DME
On the Horizon: Strategies for Surgical Success of Durable Anti-VEGF Delivery in nAMD and DME
CME/CE
On the Horizon: Achieving Durable VEGF Suppression in nAMD and DME
On the Horizon: Achieving Durable VEGF Suppression in nAMD and DME
CME/CE
Frontiers in Diabetic Macular Edema: Durable Suppression for Addressing Health Disparities
Frontiers in Diabetic Macular Edema: Durable Suppression for Addressing Health Disparities
CME/CE
Frontiers in Diabetic Macular Edema: Addressing Health Disparities and Other Barriers to Optimal Outcomes
Frontiers in Diabetic Macular Edema: Addressing Health Disparities and Other Barriers to Optimal Outcomes
CME/CE
Advances in Angiostatic Treatment for Retinal Disease: Demystifying Novel Therapeutic Targets
Advances in Angiostatic Treatment for Retinal Disease: Demystifying Novel Therapeutic Targets
CME/CE
Time Is Vision: Early Recognition and Management of Neovascular AMD and RVO
Time Is Vision: Early Recognition and Management of Neovascular AMD and RVO
news-medical.net
10/08/2021- msn.com
10/04/2021
- news-medical.net
09/24/2021
- news-medical.net
09/24/2021
- medicinenet.com
09/21/2021
- ucsdnews.ucsd.edu
08/24/2021